Novartis pauses CAR-T trials for autoimmune diseases after 3 deaths
Novartis temporarily paused eight clinical trials of its experimental CAR-T therapy in late August after three patients died from a severe immune response, The Wall Street Journal reported Sept. 1. The Switzerland-based drugmaker was testing the treatment — called rap-cel — in patients with lupus, multiple sclerosis and other autoimmune disorders. The timeline of the […] The post Novartis pauses CAR-T trials for autoimmune diseases after 3 deaths appeared first on Becker's Hospital Re...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.